SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-002383
Filing Date
2018-01-16
Accepted
2018-01-16 16:18:03
Documents
33
Period of Report
2017-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-29073_110q.htm 10-Q 354548
2 EX-31.1 a17-29073_1ex31d1.htm EX-31.1 10857
3 EX-31.2 a17-29073_1ex31d2.htm EX-31.2 10829
4 EX-32.1 a17-29073_1ex32d1.htm EX-32.1 6322
5 EX-32.2 a17-29073_1ex32d2.htm EX-32.2 6297
  Complete submission text file 0001104659-18-002383.txt   1329754

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20171130.xml EX-101.INS 168737
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20171130.xsd EX-101.SCH 14801
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20171130_cal.xml EX-101.CAL 16891
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20171130_lab.xml EX-101.LAB 137962
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20171130_pre.xml EX-101.PRE 86506
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20171130_def.xml EX-101.DEF 32390
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 18528790
SIC: 2835 In Vitro & In Vivo Diagnostic Substances